< Back to all clusters
[BUSINESS] · 3 sources

started · updated

Lantheus and Cellectis Report Quarterly Earnings Beats

Lantheus Holdings Inc. posted first‑quarter earnings of $1.55 per share, surpassing analysts' estimate of $1.30. Revenue reached $388.18 million, up 2.7% year‑over‑year, with a net margin of 17.69% and a return on equity of 28.10%. The stock slipped $0.12 in after‑hours trading to $100.95.

Cellectis SA reported a loss of $0.22 per share for the quarter, beating the consensus loss estimate of $0.26. Revenue was $6.90 million, well below the $11.05 million forecast. The company posted a negative net margin of 102.34% and a negative return on equity of 82.92%. Its shares rose $0.15 during midday trading to $2.84.

Entities

Aldeyra Therapeutics Inc. · Cellectis SA · Lantheus Holdings Inc. · Todd C. Brady